Abstract: The mobile device receives a prediction result via a digital cellular mobile telecommunication network. The prediction result has been generated by a program logic using a biomedical model. The prediction result includes a prediction score, a first confidence interval of prediction scores known to have a percentage of false negative predictions below a predefined FN-percentage threshold and a second confidence interval of score values known to have a percentage of false positive predictions below a predefined FP-percentage threshold. The mobile device displays an analog scale icon including a background area having the prediction score, an analog scale representing the score range; a pointer; a first sub-range indicator indicating the size and position of the first confidence interval; and a second sub-range indicator indicating the size and position of the second confidence interval within the score range.

Abstract: The present invention relates to a method and a system for providing a customer biopolymer to a customer. The sequence of a customer biopolymer is transferred to a production control system of a biopolymer service provider, synthesized on a production machine of the service provider and delivered to the customer, wherein no human action is necessary to initiate or control the synthesis process.

Abstract: The present invention relates to a method and a system for providing a customer biopolymer to a customer. The sequence of a customer biopolymer is transferred to a production control system of a biopolymer service provider, synthesized on a production machine of the service provider and delivered to the customer, wherein no human action is necessary to initiate or control the synthesis process.